A number of clinical trials demonstrated that positive and high PD-L1 expression is associated with larger tumour size, nerve and blood vessel invasion, as well as lymph node metastasis in NSCLC and other location malignancies [53,54]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.